ZINClick: A database of 16 million novel, patentable, and readily synthesizable 1,4-disubstituted triazoles

Journal of Chemical Information and Modeling

Volumn 54, Issue 2, 2014, Pages 396-406

  Massarotti, Alberto ^a   Brunco, Angelo ^a   Sorba, Giovanni ^a   Tron, Gian Cesare ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DATABASE SYSTEMS; DIGITAL LIBRARIES; HYDROCARBONS; SALTS;

1 ,3-DIPOLARCYCLOADDITION; BIOACTIVE MOLECULES; CHEMICAL FEATURES; DRUG-RECEPTOR INTERACTIONS; MEDICINAL CHEMISTRY; METABOLIC PROFILES; STRUCTURAL DIVERSITY; VIRTUAL LIBRARIES;

CYCLOADDITION;

ALKYNE; AZIDE; DRUG DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN KINASE INHIBITOR; TRIAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLICK CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG DATABASE; MOLECULAR LIBRARY; PATENT; SYNTHESIS;

ALKYNES; AZIDES; CLICK CHEMISTRY; DATABASES, PHARMACEUTICAL; GLYCOGEN SYNTHASE KINASE 3; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NADP; PATENTS AS TOPIC; PROTEIN KINASE INHIBITORS; SMALL MOLECULE LIBRARIES; TRIAZOLES;

EID: 84894682443     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci400529h     Document Type: Article

References (80)

1. Walters, W. P.; Stahl, M. T.; Murcko, M. A. Virtual screening-An overview Drug Discovery Today 1998, 3, 160-178
2. Shoichet, B. K. Virtual screening of chemical libraries Nature 2004, 432, 862-865
3. Scior, T.; Bender, A.; Tresadern, G.; Medina-Franco, J. L.; Martinez-Mayorga, K.; Langer, T.; Cuanalo-Contreras, K.; Agrafiotis, D. K. Recognizing pitfalls in virtual screening: A critical review J. Chem. Inf. Model. 2012, 52, 867-881
4. Good, A. C.; Oprea, T. I. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? J. Comput.-Aided Mol. Des. 2008, 22, 169-178
5. Schneider, G. Virtual screening: An endless staircase? Nat. Rev. Drug Discovery 2010, 9, 273-276
6. Alvarez, J.; Shoichet, B. Virtual Screening in Drug Discovery, 1 ed.; CRC Press: Boca Raton, FL, 2005; p 470.
7. Sotriffer, C. Virtual Screening: Principles, Challenges, and Practical Guidelines, 1 ed.; Wiley-VCH: Weinheim, DE, 2011; Vol. 48, p 519.
8. Chemistry Databases and Search Services on the Web. http://cactus.nci. nih.gov/links/chem-www.html (accessed August 31, 2013).
9. Irwin, J. J.; Shoichet, B. K. ZINC-A free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182
10. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A free tool to discover chemistry for biology J. Chem. Inf. Model. 2012, 52, 1757-1768
11. Available Chemicals Directory (ACD). http://www.akosgmbh.de/Symyx/ software/databases/acd.htm.
12. Dorschner, K. V.; Toomey, D.; Brennan, M. P.; Heinemann, T.; Duffy, F. J.; Nolan, K. B.; Cox, D.; Adamo, M. F.; Chubb, A. J. TIN: A combinatorial compound collection of synthetically feasible multicomponent synthesis products J. Chem. Inf. Model. 2011, 51, 986-995
13. Tron, G. C. Off the beaten track: The use of secondary amines in the Ugi reaction Eur. J. Org. Chem. 2013, 2013, 1849-1859
14. Fink, T.; Reymond, J. L. Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery J. Chem. Inf. Model. 2007, 47, 342-353
15. Blum, L. C.; Reymond, J. L. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13 J. Am. Chem. Soc. 2009, 131, 8732-8733
16. Ruddigkeit, L.; van Deursen, R.; Blum, L. C.; Reymond, J. L. Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17 J. Chem. Inf. Model. 2012, 52, 2864-2875
17. Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Analysis of the reactions used for the preparation of drug candidate molecules Org. Biomol. Chem. 2006, 4, 2337-2347
18. Roughley, S. D.; Jordan, A. M. The medicinal chemist's toolbox: An analysis of reactions used in the pursuit of drug candidates J. Med. Chem. 2011, 54, 3451-3479
19. Fullbeck, M.; Michalsky, E.; Dunkel, M.; Preissner, R. Natural products: Sources and databases Nat. Prod. Rep. 2006, 23, 347-356
20. Chuprina, A.; Lukin, O.; Demoiseaux, R.; Buzko, A.; Shivanyuk, A. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers J. Chem. Inf. Model. 2010, 50, 470-479
21. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click chemistry: Diverse chemical function from a few good reactions Angew. Chem., Int. Ed. Engl. 2001, 40, 2004-2021
22. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes Angew. Chem., Int. Ed. Engl. 2002, 41, 2596-2599
23. Tornoe, C. W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides J. Org. Chem. 2002, 67, 3057-3064
24. Wu, P.; Fokin, V. V. Catalytic azide-alkyne cycloaddition: Reactivity and applications Aldrichim. Acta 2007, 40, 7-17
25. Bock, V. D.; Hiemstra, H.; van Maarseveen, J. H. CuI-catalyzed alkyne-azide "click" cycloadditions from a mechanistic and synthetic perspective Eur. J. Org. Chem. 2006, 2006, 51-68
26. Meldal, M.; Tornoe, C. W. Cu-catalyzed azide-alkyne cycloaddition Chem. Rev. 2008, 108, 2952-3015
27. Hein, J. E.; Fokin, V. V. Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: New reactivity of copper(I) acetylides Chem. Soc. Rev. 2010, 39, 1302-1315
28. Sharpless, K. B. Secret Life of Enzymes: An Aggressive Strategy for Drug Discovery. Abstract of Papers, 229th ACS National Meeting, American Chemical Society: San Diego, CA, United States, 2005; pp ORGN-611.
29. Rydzewski, R. M. Real World Drug Discovery. 1 ed.; Elsevier Ltd.: 2008.
30. Hein, C. D.; Liu, X. M.; Wang, D. Click chemistry, a powerful tool for pharmaceutical sciences Pharm. Res. 2008, 25, 2216-2230
31. Kolb, H. C.; Sharpless, K. B. The growing impact of click chemistry on drug discovery Drug Discovery Today 2003, 8, 1128-1137
32. Moses, J. E.; Moorhouse, A. D. The growing applications of click chemistry Chem. Soc. Rev. 2007, 36, 1249-1262
33. Moorhouse, A. D.; Moses, J. E. Click chemistry and medicinal chemistry: A case of "cyclo-addiction" ChemMedChem 2008, 3, 715-723
34. Tron, G. C.; Pirali, T.; Billington, R. A.; Canonico, P. L.; Sorba, G.; Genazzani, A. A. Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes Med. Res. Rev. 2008, 28, 278-308
35. Agalave, S. G.; Maujan, S. R.; Pore, V. S. Click chemistry: 1,2,3-Triazoles as pharmacophores Chem. Asian J. 2011, 6, 2696-2718
36. Thirumurugan, P.; Matosiuk, D.; Jozwiak, K. Click chemistry for drug development and diverse chemical-biology applications Chem. Rev. 2013, 113, 4905-4979
37. Reactor, version 6.0.4, ChemAxon, 2013. http://www.chemaxon.com.
38. Suite 2012: Maestro, version 9.3; Schrödinger, LLC: New York, 2012.
39. Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc.: Montreal, QC, Canada, 2012.
40. e-LEA3D: ChemInformatic Tools and Databases. http://chemoinfo.ipmc.cnrs. fr/eDESIGN/reagent.html (accessed September 2, 2013).
41. Douguet, D. e-LEA3D: A computational-aided drug design Web server Nucleic Acids Res. 2010, 38, W615-W621
42. Durrant, J. D.; McCammon, J. A. AutoClickChem: Click chemistry in silico PLoS Comput. Biol. 2012, 8, e1002397
43. R Core Team. R: A Language and Environment for Statistical Computing, version 3.0.1; R Foundation for Statistical Computing: Vienna, Austria, 2013. http://www.R-project.org.
44. The PyMOL Molecular Graphics System, version 1.3; Schrödinger LLC: 2010.
45. SciFinder®. http://scifinder.cas.org.
46. Tubert-Brohman, I. Perl and chemistry Perl J. 2004, 8, 3-5
47. Tubert-Brohman, I. PerlMol-Perl modules for molecular chemistry, 2004. http://www.perlmol.org.
48. OMEGA, version 2.4.6; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
49. Hawkins, P. C. D.; Skillman, A. G.; Warren, G. L.; Ellingson, B. A.; Stahl, M. T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database J. Chem. Inf. Model. 2010, 50, 572-584
50. Hawkins, P. C. D.; Nicholls, A. Conformer generation with OMEGA: Learning from the data set and the analysis of failures J. Chem. Inf. Model. 2012, 52, 2919-2936
51. FILTER, version 2.0.2; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
52. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs Nucleic Acids Res. 2011, 39, D1035-1041
53. Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 2000, 44, 235-249
54. Teague, S. J.; Davis, A. M.; Leeson, P. D.; Oprea, T. The design of leadlike combinatorial libraries Angew. Chem., Int. Ed. Engl. 1999, 38, 3743-3748
55. Carr, R. A.; Congreve, M.; Murray, C. W.; Rees, D. C. Fragment-based lead discovery: Leads by design Drug Discovery Today 2005, 10, 987-992
56. chemfp, version 1.1; Dalke Scientific: Sweden, 2013. http://chemfp.com.
57. OEChem TK, Python version 1.7.7; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
58. GraphSim TK, Python version 2.0.1; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
59. ChemFP Substruct keys. http://code.google.com/p/chem-fingerprints/wiki/ Substruct (accessed September 4, 2013).
60. Voigt, J. H.; Bienfait, B.; Wang, S.; Nicklaus, M. C. Comparison of the NCI open database with seven large chemical structural databases J. Chem. Inf. Comput. Sci. 2001, 41, 702-712
61. Baell, J. B.; Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 2010, 53, 2719-2740
62. Guha, R. PAINS Substructure Filters as SMARTS. http://blog.rguha.net/?p= 850 (accessed July 4, 2013).
63. Bender, A.; Glen, R. C. Molecular similarity: A key technique in molecular informatics Org. Biomol. Chem. 2004, 2, 3204-3218
64. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do structurally similar molecules have similar biological activity? J. Med. Chem. 2002, 45, 4350-4358
65. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical similarity searching J. Chem. Inf. Comp. Sci. 1998, 38, 983-996
66. Overington, J. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr J. Comput.-Aided. Mol. Des. 2009, 23, 195-198
67. Sink, R.; Gobec, S.; Pecar, S.; Zega, A. False positives in the early stages of drug discovery Curr. Med. Chem. 2010, 17, 4231-4255
68. Baell, J. B. Observations on screening-based research and some concerning trends in the literature Fut. Med. Chem. 2010, 2, 1529-1546
69. Naylor, E.; Arredouani, A.; Vasudevan, S. R.; Lewis, A. M.; Parkesh, R.; Mizote, A.; Rosen, D.; Thomas, J. M.; Izumi, M.; Ganesan, A.; Galione, A.; Churchill, G. C. Identification of a chemical probe for NAADP by virtual screening Nat. Chem. Biol. 2009, 5, 220-226
70. ROCS, version 2.4.1; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
71. Hawkins, P. C. D.; Skillman, A. G.; Nicholls, A. Comparison of shape-matching and docking as virtual screening tools J. Med. Chem. 2007, 50, 74-82
72. EON, version 2.0.1; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
73. Muchmore, S. W.; Souers, A. J.; Akritopoulou-Zanze, I. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist Chem. Biol. Drug Des. 2006, 67, 174-176
74. Kubota, M.; Sakaguchi, H.; Kandoh, Y. Preparation of naphthyridinecarboxamides for plant disease control. Patent WO2009093640 (A1), 2009.
75. Barral, K.; Moorhouse, A. D.; Moses, J. E. Efficient conversion of aromatic amines into azides: A one-pot synthesis of triazole linkages Org. Lett. 2007, 9, 1809-1811
76. Osolodkin, D. I.; Palyulin, V. A.; Zefirov, N. S. Structure-based virtual screening of glycogen synthase kinase 3β inhibitors: Analysis of scoring functions applied to large true actives and decoy sets Chem. Biol. Drug Des. 2011, 78, 378-390
77. FRED, version 3.0.0; OpenEye Scientific Software: Santa Fe, NM. http://www.eyesopen.com.
78. McGann, M. FRED pose prediction and virtual screening accuracy J. Chem. Inf. Model. 2011, 51, 578-596
79. Li, Z.; Sun, H.; Jiang, H.; Liu, H. Copper-catalyzed intramolecular cyclization to N-substituted 1,3-dihydrobenzimidazol-2-ones Org. Lett. 2008, 10, 3263-3266
80. Jia, Z.; Zhu, Q. 'Click' assembly of selective inhibitors for MAO-A Bioorg. Med. Chem. Lett. 2010, 20, 6222-6225